Liang et al. transplanted the cisplatin-resistant human ovarian cancer cell line A2780/DDP into nude rats to study drug intervention and found that HSYA enhanced the sensitivity of A2780/DDP to cisplatin by downregulating the PI3K/AKT pathway and inhibiting the p-AKT protein [105]. The gene discussed is AKT1; the disease is ovarian cancer.